Immunogenicity of different nanoparticle adjuvants containing recombinant RBD coronavirus antigen in animal model
Description
Ongoing mutations of SARS-CoV-2 present challenges for vaccine development, promising renewed global efforts to create more effective vaccines against coronavirus disease (COVID-19). One approach is to target highly immunogenic viral proteins, such
